Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

HLN stock hub

Haleon plc has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HLNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

40.1B

NYSE

Market data

Live price

Current market quote for this ticker.

Current price

HLN

In the news

Latest news · HLN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E16.1

P25 12.3P50 18.4P75 33.1

Trailing P/E17.9

P25 14.9P50 23.2P75 38.5

ROE10.3

P25 -105.6P50 -46.5P75 -3.1

ROIC8.2

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HLN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

239

Groups with data

Currency

GBP

Showing 239 of 239 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001900304
Company name	Haleon plc
Country	United Kingdom
Country code	US
Cusip	405552100
Employees	24,535
Employees Change	-26%
Employees Change Percent	-0.11
Enterprise value	$50.1B
Exchange	NYSE
Financial currency	GBP
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
Isin	US4055521003
Last refreshed	2026-05-10
Market cap	$40.1B
Market cap category	Large-Cap
Price	$9.11
Price currency	USD
Rev Per Employee	605,063.06x
Sector	Healthcare
Sic	2844
Symbol	HLN
Website	https://www.haleon.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.6%
EV Earnings	22.32x
EV/EBIT	14.87x
EV/EBITDA	13.56x
EV/FCF	15.89x
EV/Sales	3.37x
FCF yield	7.87%
Forward P/E	16.15x
P/B ratio	1.81x
P/E ratio	17.86x
P/S ratio	2.7x
PE Ratio3 Y	25.03x
PE Ratio5 Y	24.81x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	22.69%
EBITDA Margin	24.87%
FCF margin	21.23%
Gross margin	64.77%
Gross Profit	$9.6B
Gross Profit Growth	0.58%
Gross Profit Growth Q	-0.14%
Gross Profit Growth3 Y	2.01%
Net Income	$2.2B
Net Income Growth	15.6%
Net Income Growth Q	86.36%
Net Income Growth Years	2%
Net Income Growth3 Y	16.29%
Pretax Margin	19.51%
Profit Margin	15.11%
Profit Per Employee	$91,445
Profitable Years	7
ROA	4.67
Roa5y	4.32
ROCE	9.04
ROE	10.27
Roe5y	7.32
ROIC	8.22
Roic5y	7.01

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-13.78%
Cagr3y	3.02%
EPS Growth	17.83
EPS Growth Q	92.03
EPS Growth Years	2
EPS Growth3 Y	17.25
FCF Growth	12.73%
FCF Growth3 Y	9.54%
OCF Growth	14.47%
OCF Growth3 Y	8.49%
Revenue Growth	-1.81x
Revenue Growth Q	0.58x
Revenue Growth Years	0x
Revenue Growth3 Y	0.53x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.33
Assets	$43.9B
Cash	$1.8B
Current Assets	$6.2B
Current Liabilities	$6.7B
Debt	$11.6B
Debt EBITDA	$3.09
Debt Equity	$0.52
Debt FCF	$3.69
Equity	$22.2B
Interest Coverage	7.21
Liabilities	$21.7B
Long Term Assets	$37.7B
Long Term Liabilities	$15B
Net Cash	$-9.8B
Net Cash By Market Cap	$-24.46
Net Debt EBITDA	$2.66
Net Debt Equity	$0.44
Net Debt FCF	$3.11
Tangible Book Value	$-12.4B
Tangible Book Value Per Share	$-1.39
WACC	5.06

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.92
Inventory Turnover	3.51
Net Working Capital	$-1.2B
Quick ratio	0.68
Working Capital	$-515.5M
Working Capital Turnover	$-62.24

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.62%
Dividend Growth	1.8%
Dividend Growth Years	3%
Dividend per share	$0.18
Dividend Years	4
Dividend Yield	1.98%
Ex Div Date	2026-04-10
Last Dividend	$0.12
Payout Frequency	Semi-Annual
Payout Ratio	72.5%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-13.77%
200-day SMA	9.8
3Y total return	9.33%
50-day SMA	9.87
50-day SMA vs 200-day SMA	50over200
All Time High	11.42
All Time High Change	-20.23%
All Time High Date	2025-06-02
All Time Low	5.59
All Time Low Change	62.97%
All Time Low Date	2022-09-02
ATR	0.18
Beta	0.25
Ch YTD	-9.89
High	9.18
High52	11.42
High52 Date	2025-06-02
High52ch	-20.23%
Low	9.07
Low52	8.71
Low52 Date	2025-09-25
Low52ch	4.59%
Ma50ch	-7.68%
Premarket Change Percent	-1.61
Premarket Price	$9.15
Premarket Volume	502,866
Price vs 200-day SMA	-7.01%
RSI	34.13
RSI Monthly	47.14
RSI Weekly	35.12
Sharpe ratio	-0.78x
Sortino ratio	-0.81
Total Return	3.61%
Tr YTD	-8.76
Tr1m	-6.64%
Tr1w	-2.88%
Tr3m	-15.99%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Buy
Earnings Revenue Estimate	15,410,000,000x
Earnings Revenue Estimate Growth	7.34x
Operating Income	$3.4B
Operating Income Growth	0.64
Operating Income Growth Q	1.9
Operating Income Growth3 Y	1.47
Operating margin	22.69

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	8,832,320,410%
Float Percent	99.15%
Net Borrowing	-1,862,268,477.5
Shares Insiders	0.06%
Shares Institutions	93.88%
Shares Out	8,908,384,504
Shares Qo Q	0%
Shares Yo Y	-1.62%
Short Float	0.14%
Short Ratio	1.5
Short Shares	0.14

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$3B
Average Volume	8,855,793.9x
Bv Per Share	2.48
CAPEX	$-433.4M
Ch1m	-7.79
Ch1w	-2.88
Ch1y	-15.33
Ch3m	-17.03
Ch3y	3.64
Ch6m	-3.7
Change	-2.04%
Change From Open	-0.65
Close	9.3
Days Gap	-1.4
Depreciation Amortization	327,192,119
Dollar Volume	182,854,453.3
Earnings Date	2026-02-26
Earnings Time	bmo
EBIT	$3.4B
EBITDA	$3.7B
EPS	$0.25
F Score	7
FCF	$3.2B
FCF EV Yield	6.29x
FCF Per Share	$0.35
Financing CF	-4,230,148,048
Fiscal Year End	December
Founded	2,022
Goodwill	11,079,543,130.7
Graham Number	7.60776
Graham Upside	-16.49
Income Tax	$635.3M
Investing CF	-465,679,677
Is Primary Listing	0
Is Spac	No
Last Earnings Date	2026-02-26
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-13
Lynch Fair Value	$8.31
Lynch Upside	-8.8
Ma150	9.89
Ma150ch	-7.91%
Ma20	9.46
Ma20ch	-3.67%
Net CF	-1,216,689,098
Next Earnings Date	2026-07-30
Open	9.17
Optionable	Yes
P FCF Ratio	12.71
P OCF Ratio	11.3
Payment Date	2026-05-14
Position In Range	36.36
Post Close	9.11
Postmarket Change Percent	-0.22
Postmarket Price	$9.09
Ppne	2,722,511,090.4
Pre Close	9.3
Price Date	2026-05-08
Price EBITDA	$10.85
Relative Volume	2.27x
Revenue	14,845,222,071x
SBC By Revenue	0.78x
Share Based Comp	115,746,972
Tax By Revenue	4.28x
Tax Rate	21.93%
Tr6m	-2.49%
Volume	20,071,839
Z Score	3.02

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

HLN dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.0%

$0.18 annual per share

Payout ratio

+72.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

3 consecutive years of growth

Total shareholder yield

+3.6%

Next ex-dividend date: 2026-04-10

Performance

HLN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HLN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+93.9%

Float: +99.1% of shares outstanding

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

HLN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

34.1

Neutral momentum band

Price vs 200-day MA

-7.0%

50/200-day relationship not available

Beta (5Y)

0.25

Less volatile than the market

Sharpe ratio

-0.78

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HLN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current HLN stock rating?

Haleon plc is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full HLN analysis?

The full report lives at /stocks/HLN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for HLN?

The latest report frames HLN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the HLN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.